High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.
BACKGROUND
Obesity induced by high fat (HF) diet is associated with inflammation which contributes to development of insulin resistance. Most prior studies have focused on adipose tissue as the source of obesity-associated inflammation. Increasing evidence links intestinal bacteria to development of diet-induced obesity (DIO). This study tested the hypothesis that HF western diet and gut bacteria interact to promote intestinal inflammation, which contributes to the progression of obesity and insulin resistance.


RESULTS
Conventionally raised specific-pathogen free (CONV) and germ-free (GF) mice were given HF or low fat (LF) diet for 2-16 weeks. Body weight and adiposity were measured. Intestinal inflammation was assessed by evaluation of TNF-alpha mRNA and activation of a NF-kappaB(EGFP) reporter gene. In CONV but not GF mice, HF diet induced increases in body weight and adiposity. HF diet induced ileal TNF-alpha mRNA in CONV but not GF mice and this increase preceded obesity and strongly and significantly correlated with diet induced weight gain, adiposity, plasma insulin and glucose. In CONV mice HF diet also resulted in activation of NF-kappaB(EGFP) in epithelial cells, immune cells and endothelial cells of small intestine. Further experiments demonstrated that fecal slurries from CONV mice fed HF diet are sufficient to activate NF-kappaB(EGFP) in GF NF-kappaB(EGFP) mice.


CONCLUSIONS
Bacteria and HF diet interact to promote proinflammatory changes in the small intestine, which precede weight gain and obesity and show strong and significant associations with progression of obesity and development of insulin resistance. To our knowledge, this is the first evidence that intestinal inflammation is an early consequence of HF diet which may contribute to obesity and associated insulin resistance. Interventions which limit intestinal inflammation induced by HF diet and bacteria may protect against obesity and insulin resistance.
Ding
Shengli
S
Department of Cell & Molecular Physiology, University of North Carolina at Chapel Hill, North Carolina, United States of America. shengli_ding@med.unc.edu
Chi
Michael M
MM
Scull
Brooks P
BP
Rigby
Rachael
R
Schwerbrock
Nicole M J
NM
Magness
Scott
S
Jobin
Christian
C
Lund
Pauline K
PK
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001419:Bacteria; D015415:Biomarkers / Q000378:metabolism; D001835:Body Weight; D004041:Dietary Fats; D005786:Gene Expression Regulation; D007249:Inflammation / Q000150:complications / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D007333:Insulin Resistance; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000382:microbiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D016328:NF-kappa B / Q000378:metabolism; D009765:Obesity / Q000150:complications* / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013047:Specific Pathogen-Free Organisms; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
D015415:Biomarkers; D004041:Dietary Fats; D016328:NF-kappa B; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha
Nature. 2006 Dec 21;444(7122):1027-31
17183312
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84
17210919
J Immunol. 2004 Aug 1;173(3):1561-70
15265883
J Clin Invest. 2003 Dec;112(12):1821-30
14679177
Gastroenterology. 2009 Nov;137(5):1716-24.e1-2
19706296
J Biol Chem. 2002 Jan 11;277(2):1531-7
11606564
Diabetes. 2007 Jul;56(7):1761-72
17456850
Am J Physiol Cell Physiol. 2006 Dec;291(6):C1232-9
16807303
J Biol Chem. 2009 Dec 25;284(52):36213-36222
19858212
J Clin Invest. 2003 Dec;112(12):1796-808
14679176
N Engl J Med. 1997 Apr 10;336(15):1066-71
9091804
J Clin Invest. 2007 Jan;117(1):175-84
17200717
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15718-23
15505215
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10422-7
15240880
Nature. 1997 Oct 9;389(6651):610-4
9335502
Am J Clin Nutr. 2006 Feb;83(2):461S-465S
16470013
Nat Med. 2004 Oct;10(10):1128-32
15448687
Am J Physiol Endocrinol Metab. 2001 May;280(5):E745-51
11287357
Endocrinology. 2009 Sep;150(9):4124-34
19477937
Pathol Biol (Paris). 2008 Jul;56(5):305-9
18178333
Science. 2001 Aug 31;293(5535):1673-7
11533494
Gut. 2009 Aug;58(8):1091-103
19240062
Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E713-25
17578885
J Nutr. 2006 Jul;136(7 Suppl):1935S-1939S
16772463
Trends Endocrinol Metab. 2000 Aug;11(6):212-7
10878750
Atherosclerosis. 2005 Dec;183(2):308-15
16285994
Nature. 2002 Nov 21;420(6913):333-6
12447443
Diabetes. 2007 Oct;56(10):2541-6
17646208
Pediatrics. 2001 Jan;107(1):E13
11134477
Nat Med. 2005 Feb;11(2):191-8
15685170
Neuro Endocrinol Lett. 2006 Aug;27(4):453-8
16892000
Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1210-29
19258492
J Clin Endocrinol Metab. 1998 Aug;83(8):2907-10
9709967